1-Bromo-5-(bromomethyl)-2,4-difluorobenzene, 98%, 1g

Benzyl 4-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate, 95.0%, 1g

N-(3-Chloro-4-(((2-(methylamino)-6-(pyridin-2-yl)pyrimidin-4-yl)amino)methyl)phenyl)methanesulfonamide, 98.0%, 10mg

alpha-Galactosylceramide>95.0%(HPLC)1mg

5-Amino-1-(3-methoxyphenyl)-1H-1,2,3-triazole-4-carboxamide, 95.0%, 250mg

n-Hexane, min. 95%, for synthesis, 100 ml, glass packaging

2-Nitroimidazole, 98.0%, 5g

3-Bromo-2-chloro-5-nitroanisole, 1g

4-(2-Methoxyethyl)benzaldehyde, 1g

(5E)-5-(5-chloro-2-hydroxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 5g

4-BENZYL-2-(IODOMETHYL)-2,6,6-TRIMETHYLMORPHOLINE, 95.0%, 500mg

3-BROMO-1H-INDAZOLE-7-CARBOXYLIC ACID, 98%, 100mg

5,6,7,8-Tetrahydro-1-naphthylamine, 95.0%, 25ml